Back to Search Start Over

Olecranon Osteotomy Implant Removal Rates and Associated Complications.

Authors :
Meldrum A
Kwong C
Archibold K
Cinats D
Schneider P
Source :
Journal of orthopaedic trauma [J Orthop Trauma] 2021 May 01; Vol. 35 (5), pp. 265-270.
Publication Year :
2021

Abstract

Objective: This study reports on olecranon osteotomy implant removal rates, fixation types, and associated complications.<br />Design: Multicentre case series.<br />Setting: Patients were identified through an electronic medical database at one Level 1 trauma center and three Level 2 trauma centers.<br />Patients: Two hundred thirty-five patients were identified through the database, of which 92 patients met inclusion criteria.<br />Intervention: Patients underwent olecranon osteotomy for fixation of distal humerus fractures and the implant used was at the surgeon's discretion.<br />Main Outcome Measurement: Implant removal rate.<br />Results: Thirty-four of 92 (37.0%) patients underwent removal of implant from their olecranon osteotomy. Implant removal rates were as follows: 28 of the 63 patients for tension band wiring (TBW) (44.4%), 6 of the 18 patients for plates (33.3%), 0 of the 1 patient for cable-pin, and 0 of the 10 patients for osteotomies fixed with a screw fixation. Screw fixation was removed less frequently than TBW (P = 0.01). Screws were less commonly removed than all other fixation types (P = 0.01). TBWs (28/63) were more commonly removed than all other implants (6/29) (P < 0.05). The nonunion rate for olecranon osteotomies was 3.3%. TBWs (18/18) are more likely to be removed for implant irritation than plates. TBWs had an odds ratio of 3.29 for requiring implant removal if they were left >1 mm off of the olecranon tip.<br />Conclusion: In this study, 34 of the 92 (37%) patients undergoing an olecranon osteotomy for treatment of a distal humerus fracture required removal of olecranon implant. Screw fixation (0/10) was found to be removed less frequently than TBW fixation 28 of the 63 patients (44.4%).<br />Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.<br />Competing Interests: The authors report no conflict of interest.<br /> (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)

Details

Language :
English
ISSN :
1531-2291
Volume :
35
Issue :
5
Database :
MEDLINE
Journal :
Journal of orthopaedic trauma
Publication Type :
Academic Journal
Accession number :
33086235
Full Text :
https://doi.org/10.1097/BOT.0000000000001979